As you continue to prepare for the in-residence component of this

 
As you continue to prepare for the in-residence component of this course, be aware of how this week’s Learning Resources address psychopharmacology issues of specific age groups. How might you adapt your patient interactions and treatment strategies with children and adolescents when you address topics from earlier weeks in the course, such as depression, anxiety, or chronic pain?
For this Discussion, review this week’s Learning Resources. Select at least one topic from the course readings on child and adolescent psychopharmacology that you found challenging, and reflect on why you found this to be so. Also consider any other topics that have been challenging this term. Finally, think about what topics you hope to cover in more depth during the in-residence component.
Write a description of at least one topic from the Learning Resources on child and adolescent psychopharmacology that you found challenging, and explain why. Then, explain any other areas or topics in this course that have been challenging. Finally, explain what topics you hope to cover in more depth in-residence.
READINGS

Brown, R. T., & Sammons, M. T. (2002). Pediatric psychopharmacology: A review of new developments and recent research.Professional Psychology: Research and Practice, 33(2), 135–147.Retrieved from the Walden Library databases.
Dean, A. J., Wragg, J., Draper, J., & McDermott, B. M. (2011). Predictors of medication adherence in children receiving psychotropic medication. Chronic migraine, classification, differential diagnosis, and epidemiology. Journal of Paediatrics and Child Health, 47(6), 350–355.
dosReis, S., & Myers, M. A. (2008). Parental attitudes and involvement in psychopharmacological treatment for ADHD: A conceptual model. International Review of Psychiatry, 20(2), 135–141.Retrieved from the Walden Library databases.
Advokat, C. D., & Comaty, J. E., & Julien, R. M. (2019). Julien’s primer of drug action: A comprehensive guide to the actions, uses, and side effects of psychoactive drugs (14th ed.). New York, NY: Worth Publishers/Macmillan.

Chapter 15, “Child and Adolescent Psychopharmacology” (pp. 573-609)
Chapter 17, “Challenging Times in Mental Health” (pp. 668-679)

Preston, J. D., O’Neal, J. H., & Talaga, M. C. (2017). Handbook of clinical psychopharmacology for therapists (8th ed.). Oakland, CA: New Harbinger.

Chapter 23, “Child and Adolescent Psychopharmacology” (pp. 255-276)

Wall, C. A., Oldenkamp, C., & Swintak, C. (2010). Safety and efficacy pharmacogenomics in pediatric psychopharmacology. Primary Psychiatry, 17(5), 53–58.Retrieved from the Walden Library databases.

"Is this question part of your assignment? We Can Help!"

Essay Writing Service